<DOC>
	<DOCNO>NCT00208195</DOCNO>
	<brief_summary>The purpose study ascertain whether Depakote ER ( Divalproex ER ) efficacy treatment patient bipolar disorder manic phase , also comorbid substance abuse diagnose . It propose Depakote ER decrease score Young Mania Rating Scale Substance Abuse Time Line Follow Back .</brief_summary>
	<brief_title>Depakote ER Therapy Mania Comorbid With Substance Abuse</brief_title>
	<detailed_description>This study perform male female subject diagnosis bipolar disorder manic phase illness also comorbid diagnosis substance abuse . This population select efficacy Depakote ER population test .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>1 . Ages 19 65 . 2 . Diagnosis mania comorbid substance confirm Structured Clinical Interview DSMIV . 3 . Comorbid diagnose anxiety and/or personality disorder permit . 4 . Ability provide sign informed consent . 5 . Stable general medical health . 6 . Ability attend outpatient research clinic . 1 . Dangerous self others . 2 . Pregnancy , inability unwillingness use approve method birth control . 3 . Inability unwillingness provide sign informed consent . 4 . Diagnosis schizophrenia , major depressive disorder . 5 . Inability attend outpatient research clinic . 6 . Medical condition , would preclude use Depakote . 7 . Need ongoing treatment medication Depakote ER , antipsychotic medication . 8 . Medical instability define likelihood needing change prescription medication course study .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Bipolar Disorder</keyword>
	<keyword>Mania</keyword>
	<keyword>Substance Abuse</keyword>
	<keyword>Substance Dependence</keyword>
	<keyword>Comorbid</keyword>
</DOC>